MedPath

SOHAIB ASHRAF

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:0
Completed:1

Trial Phases

3 Phases

Phase 1:3
Phase 2:1
Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Phase 1
3 (60.0%)
Phase 2
1 (20.0%)
Phase 3
1 (20.0%)

Honey and Nigella Sativa in COVID-19 Prophylaxis

Phase 2
Conditions
Covid19
Interventions
First Posted Date
2021-02-23
Last Posted Date
2021-07-02
Lead Sponsor
Sohaib Ashraf
Target Recruit Count
1000
Registration Number
NCT04767087
Locations
🇵🇰

Shaikh Zayed Post-Graduate Medical Institute, Lahore, MA, Pakistan

Role of Alprazolam in the Management of Acute Coronary Syndrome

Phase 1
Conditions
Myocardial Infarction
Heart Diseases
Acute Coronary Syndrome
ST Elevation Myocardial Infarction
Anxiety
Interventions
Other: Placebo
First Posted Date
2021-01-20
Last Posted Date
2021-01-20
Lead Sponsor
Sohaib Ashraf
Target Recruit Count
48
Registration Number
NCT04715269
Locations
🇵🇰

Shaikh Zayed Post-Graduate Medical Institute, Lahore, Pakistan

Efficacy of Iodine Complex Against COVID-19 Patients

Phase 1
Conditions
Covid19
SARS-CoV-2
Corona Virus Infection
Interventions
Drug: Placebo
Drug: Idoine Complex
First Posted Date
2020-07-16
Last Posted Date
2021-07-07
Lead Sponsor
Sohaib Ashraf
Target Recruit Count
200
Registration Number
NCT04473261
Locations
🇵🇰

Shaikh Zayed Hospital, Lahore, Pakistan

Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients

Phase 1
Conditions
COVID
Sars-CoV2
Coronavirus Infection
Interventions
Other: Injectable Placebo
Drug: Placebo empty capsule
First Posted Date
2020-07-15
Last Posted Date
2021-02-17
Lead Sponsor
Sohaib Ashraf
Target Recruit Count
180
Registration Number
NCT04472585
Locations
🇵🇰

Ali Clinic, Lahore, MA, Pakistan

🇵🇰

Shaikh Zayed Hospital, Lahore, Punjab, Pakistan

Honey & Nigella Sativa Trial Against COVID-19

Phase 3
Completed
Conditions
Coronavirus Infection
Sars-CoV2
Interventions
Drug: Placebos
Drug: Nigella Sativa / Black Cumin
First Posted Date
2020-04-15
Last Posted Date
2020-11-12
Lead Sponsor
Sohaib Ashraf
Target Recruit Count
313
Registration Number
NCT04347382
Locations
🇵🇰

Federal Post-Graduate Medical Institute, Shaikh Zayed Hospital, Lahore, Punjab, Pakistan

🇵🇰

Services Institute of Medical Sciences, Services Hospital, Lahore, Punjab, Pakistan

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.